AtriCure 2024年第四季度调整后每股亏损$0.08,优于预期的$0.23,销售额$1.243亿,超过预期的$1.21842亿

财报速递2025-02-13
AtriCure (NASDAQ:ATRC)报告其季度每股亏损$0.08,优于分析师预期的$0.23,超出65.22%。这一结果较去年同期每股亏损$0.21增加了61.9%。公司报告其季度销售额为$1.243亿,超过分析师预期的$1.21842亿,增幅2.02%。这一结果较去年同期的$1.06543亿增长了16.67%。

以上内容来自Benzinga Earnings专栏,原文如下:

AtriCure (NASDAQ:ATRC) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.23) by 65.22 percent. This is a 61.9 percent increase over losses of $(0.21) per share from the same period last year. The company reported quarterly sales of $124.300 million which beat the analyst consensus estimate of $121.842 million by 2.02 percent. This is a 16.67 percent increase over sales of $106.543 million the same period last year.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法